Victrex (LON:VCT) Reaches New 12-Month High – Time to Buy?

Victrex plc (LON:VCT) reached a new 52-week high on Tuesday . The stock traded as high as GBX 828 and last traded at GBX 816, with a volume of 207575 shares. The stock had previously closed at GBX 819.

Analyst Ratings Changes

VCT has been the subject of a number of recent analyst reports. Berenberg Bank raised their price target on Victrex from GBX 600 to GBX 680 and gave the company a “hold” rating in a report on Wednesday, July 8th. Jefferies Financial Group reissued a “hold” rating and set a GBX 595 price objective on shares of Victrex in a report on Tuesday, July 7th. UBS Group reiterated a “sell” rating and set a GBX 575 target price on shares of Victrex in a research report on Monday, May 11th. Finally, Canaccord Genuity Group downgraded Victrex to a “buy” rating and set a GBX 725 price objective on the stock. in a report on Friday, May 15th. Two analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of GBX 663.33.

Victrex Trading Down 0.9%

The company has a market capitalization of £705.72 million, a P/E ratio of -36.16, a PEG ratio of 1.92 and a beta of 0.81. The business has a 50 day moving average price of GBX 683.16 and a 200 day moving average price of GBX 651.37. The company has a current ratio of 2.35, a quick ratio of 1.99 and a debt-to-equity ratio of 21.30.

Victrex (LON:VCT) last issued its quarterly earnings data on Monday, May 11th. The company reported GBX 17.20 EPS for the quarter. Victrex had a negative return on equity of 4.95% and a negative net margin of 6.70%.The business had revenue of £147.10 million for the quarter. Analysts anticipate that Victrex plc will post 73.1078905 EPS for the current year.

Victrex Company Profile

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.